Circulating CD34+ cells: An adverse prognostic factor in the myelodysplastic syndromes
β Scribed by Sally A. Sullivan; Katherine A. Marsden; Raymond M. Lowenthal; David M. Jupe; Michael E. Jones
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 534 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The potential role of paraneoplastic Cushing's syndrome (CS) was assessed on the clinical course of patients with small cell lung cancer. A retrospective comparison was done of complications and survival rates according to the presence or absence of CS in patients with small cell lung cancer who die
## Abstract ## BACKGROUND Vascular endothelial growth factor (VEGF) and its receptors (VEGFRs) are major regulators of angiogenesis, which plays a key role in the growth and dissemination of solid tumors and hematologic neoplasms. ## METHODS The authors measured the plasma concentrations of solu
## Abstract Detection of circulating tumor cells (CTCs) might improve current staging procedures by identifying a subgroup of patients with minimal residual disease and thus a higher risk of disease recurrence. Forty patients with β₯2βmmβthick cutaneous melanoma with or without lymph node metastasis